Colorado Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Colorado Health Reporter.

Press releases published on October 1, 2026

Oct. 1, 2026

Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

MitoRx Therapeutics presents new preclinical data on MTRX31, demonstrating restored mitochondrial density, at the 62nd EASD Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

What Are the 5 Signs of Poor Metabolic Health Adults May Overlook?

Indeterminate GlobeNewswire

Oct. 1, 2026

Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD Risk

Indeterminate GlobeNewswire

Oct. 1, 2026

Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities

Indeterminate GlobeNewswire

Oct. 1, 2026

Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences

Indeterminate GlobeNewswire

Oct. 1, 2026

Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors

Indeterminate GlobeNewswire

Oct. 1, 2026

Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer

Indeterminate GlobeNewswire

Oct. 1, 2026

BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio

Indeterminate GlobeNewswire

Oct. 1, 2026

Canadians Invited to “Carry the Weight” this October – For Kids Like Hamdiya

Indeterminate GlobeNewswire

Oct. 1, 2026

Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 1, 2026

Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease

Indeterminate GlobeNewswire

Oct. 1, 2026

Nxera Announces Successful Resolution of miniG Patent Infringement Action

Indeterminate GlobeNewswire

Oct. 1, 2026

RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals

Indeterminate GlobeNewswire

Oct. 1, 2026

Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies

Indeterminate GlobeNewswire

Oct. 1, 2026

Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board

Indeterminate GlobeNewswire